BlackRock Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.36M Buy
53,652
+328
+0.6% +$7.28K ﹤0.01% 2487
2016
Q3
$1.06M Buy
53,324
+4,572
+9% +$79.9K ﹤0.01% 2632
2016
Q2
$696K Buy
48,752
+3,083
+7% +$47.1K ﹤0.01% 2869
2016
Q1
$709K Buy
45,669
+333
+0.7% +$4.78K ﹤0.01% 2719
2015
Q4
$782K Buy
45,336
+822
+2% +$11.9K ﹤0.01% 2761
2015
Q3
$543K Buy
44,514
+3,329
+8% +$42.7K ﹤0.01% 2995
2015
Q2
$497K Buy
41,185
+39,056
+1,834% +$384K ﹤0.01% 3122
2015
Q1
$18K Hold
2,129
﹤0.01% 3471
2014
Q4
$16K Hold
2,129
﹤0.01% 3510
2014
Q3
$15K Buy
2,129
+160
+8% +$1.2K ﹤0.01% 3508
2014
Q2
$16K Buy
+1,969
New +$15.4K ﹤0.01% 3471

Other funds holding LMAT

BlackRock Investment Management's LMAT Position: Q4 2016 in Review

BlackRock Investment Management increased its LeMaitre Vascular (LMAT) stake by 0.62% in Q4 2016, buying an estimated $7.28K and bringing the position to 53,652 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2487.

BlackRock Investment Management first reported a position in LMAT in Q2 2014 and has held it in 11 quarters since. 112 funds tracked by Wall St. Rank hold LMAT as of Q4 2016.

  • BlackRock Investment Management held 53,652 shares of LeMaitre Vascular worth $1.36M as of Q4 2016.
  • BlackRock Investment Management bought 328 LeMaitre Vascular shares in Q4 2016, an estimated $7.28K.
  • LeMaitre Vascular made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2487 holding.
  • BlackRock Investment Management first reported a position in LeMaitre Vascular in Q2 2014 and has held it in 11 quarters since.
  • 112 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.